Evidence map›Paper›PMID 40296623›Full record

ArticleCombinatorial chemistry & high throughput screening2026

HuangE Capsules Improve Bladder Function in BOO-induced Overactive Bladder Rats: Network Pharmacology and Experimental Validation.

Peizhe Li, Yuewen Pang, Shiyu Zhao, Heyang Liu, Siyu Han, Ran Zhong, Shuang He, Jing Shi, Haisheng Cheng, Huijie Gong and 2 more

Abstract read
In one paragraph

Article in Combinatorial chemistry & high throughput screening, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Peizhe LiDepartment of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Yuewen PangDepartment of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Shiyu ZhaoDepartment of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Heyang LiuDepartment of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Siyu HanDepartment of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Ran ZhongDepartment of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Shuang HeDepartment of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Jing ShiDepartment of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Haisheng ChengDepartment of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Huijie GongDepartment of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Yongji YanDepartment of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Junyao DuanDepartment of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsOur objective is to assess the therapeutic impact of HEC on OAB rats and investigate potential mechanisms.

backgroundOveractive bladder (OAB) is a syndrome of urinary storage symptoms characterized by "urinary urgency with or without urinary acute incontinence, usually accompanied by increased daytime and nocturnal urination", which impacts patients' quality of life. We found the potential therapeutic impact of HuangE capsules (HEC) on OAB patients through clinical practice. However, the exact effect and mechanism of action remain unclear.

methodsWe developed a "drugs- active ingredients- targets- diseases" network and employed the pathway enrichment analysis to identify the potential mechanisms of HEC on OAB. Bladder outlet obstruction (BOO) models and sham-operated ones were established in healthy male Wistar rats through surgical procedures. Following 28 days of continuous gavage administration of HEC, saturated copper sulfate test paper was utilized to quantify the frequency of urination over a 24-hour period. Subsequently, cystostomy was conducted to perform cystometry, and Masson staining was applied to a portion of the bladder tissue. Finally, we investigated the Rho/Rho-kinase pathway's expression and assessed the oxidative stress and inflammatory factor levels in the rat bladder through western blotting and ELISA techniques.

resultsThrough network pharmacological analysis, we identified RhoA/Rho-kinase pathway and cytokine including TNF-α, IL-6, SOD and MDA as potential mechanisms of HEC on OAB. The rats in the 2× HuangE group exhibited significantly enhanced urodynamic outcomes and decreased 24-hour urination frequency compared to the model group. Masson staining indicated a decrease in the proportion of collagenous tissue and an improvement in histomorphology. We observed a decrease expression of RhoA, ROCK1, and ROCK2 protein in the bladder tissue of 2× HuangE group rats, along with elevated SOD levels and decreased levels of TNF-α, IL-6, and MDA. DISCUSSION: Mechanistically, HEC suppressed the Rho/Rho-kinase pathway in bladder tissue, reducing the expression of RhoA, ROCK1, and ROCK2, while decreasing inflammatory cytokines and oxidative stress, thereby alleviating fibrosis and improving urodynamics. Given that HEC also inhibits prostatic proliferation, a synergistic benefit for OAB patients with BPH is plausible. Gender differences and efficacy in neurogenic OAB warrant further investigation. Overall, HEC is a promising multi-target TCM option for OAB, though clinical validation remains necessary.

conclusionHEC could improve bladder function and morphology in BOO-induced OAB rats by reducing the expression of RhoA, ROCK1, and ROCK2 and lowering levels of oxidative stress and inflammation.

Indexed as

Drugs, Chinese HerbalNetwork PharmacologyUrinary BladderUrinary Bladder Neck ObstructionUrinary Bladder, OveractiveAnimalsCapsulesDisease Models, AnimalMaleOxidative StressRatsRats, Wistarrho-Associated KinasesCapsulesDrugs, Chinese Herbalrho-Associated Kinasesbladder functionbladder outlet obstructionBOO-inducedHuangE capsulesnetwork pharmacologyOveractive bladderROCK1ROCK2urology

Identifiers

PMID40296623
PMCPMC13621371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.